GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) » Definitions » Piotroski F-Score

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Piotroski F-Score : 4 (As of Mar. 28, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents has an F-score of 4 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Piotroski F-Score or its related term are showing as below:

CAI:RMDA' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 4   Max: 7
Current: 4

During the past 7 years, the highest Piotroski F-Score of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents was 7. The lowest was 3. And the median was 4.


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Piotroski F-Score Historical Data

The historical data trend for Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Piotroski F-Score Chart

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Piotroski F-Score
Get a 7-Day Free Trial 3.00 7.00 7.00 3.00 4.00

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 3.00 5.00 5.00 4.00

Competitive Comparison of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Piotroski F-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Piotroski F-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Piotroski F-Score falls into.


;
;

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Net Income was 57.009 + 61.836 + 115.678 + 152.844 = E£387 Mil.
Cash Flow from Operations was -65.7 + 61.907 + 20.109 + -323.236 = E£-307 Mil.
Revenue was 456.233 + 564.906 + 763.229 + 984.32 = E£2,769 Mil.
Gross Profit was 197.64 + 270.789 + 347.088 + 468.147 = E£1,284 Mil.
Average Total Assets from the begining of this year (Dec23)
to the end of this year (Dec24) was
(3218.272 + 3361.485 + 3244.372 + 3591.972 + 4311.316) / 5 = E£3545.4834 Mil.
Total Assets at the begining of this year (Dec23) was E£3,218 Mil.
Long-Term Debt & Capital Lease Obligation was E£7 Mil.
Total Current Assets was E£3,137 Mil.
Total Current Liabilities was E£2,155 Mil.
Net Income was 66.514 + 49.161 + 76.289 + 52.896 = E£245 Mil.

Revenue was 392.002 + 450.432 + 545.725 + 534.192 = E£1,922 Mil.
Gross Profit was 178.754 + 207.971 + 265.091 + 254.099 = E£906 Mil.
Average Total Assets from the begining of last year (Dec22)
to the end of last year (Dec23) was
(2773.031 + 2879.229 + 3154.671 + 3269.905 + 3218.272) / 5 = E£3059.0216 Mil.
Total Assets at the begining of last year (Dec22) was E£2,773 Mil.
Long-Term Debt & Capital Lease Obligation was E£12 Mil.
Total Current Assets was E£2,023 Mil.
Total Current Liabilities was E£1,373 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's current Net Income (TTM) was 387. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's current Cash Flow from Operations (TTM) was -307. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec23)
=387.367/3218.272
=0.1203649

ROA (Last Year)=Net Income/Total Assets (Dec22)
=244.86/2773.031
=0.08830049

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's return on assets of this year was 0.1203649. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's return on assets of last year was 0.08830049. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's current Net Income (TTM) was 387. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's current Cash Flow from Operations (TTM) was -307. ==> -307 <= 387 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=7.19/3545.4834
=0.00202793

Gearing (Last Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=11.7/3059.0216
=0.00382475

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's gearing of this year was 0.00202793. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's gearing of last year was 0.00382475. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec24)=Total Current Assets/Total Current Liabilities
=3137.015/2155.199
=1.455557

Current Ratio (Last Year: Dec23)=Total Current Assets/Total Current Liabilities
=2022.951/1372.839
=1.47355298

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's current ratio of this year was 1.455557. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's current ratio of last year was 1.47355298. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's number of shares in issue this year was 1521.675. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's number of shares in issue last year was 1514.909. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1283.664/2768.688
=0.46363621

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=905.915/1922.351
=0.47125369

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's gross margin of this year was 0.46363621. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's gross margin of last year was 0.47125369. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec23)
=2768.688/3218.272
=0.86030267

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec22)
=1922.351/2773.031
=0.69323098

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's asset turnover of this year was 0.86030267. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's asset turnover of last year was 0.69323098. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+0+1+0+1+0+0+0+1
=4

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents has an F-score of 4 indicating the company's financial situation is typical for a stable company.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents  (CAI:RMDA) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Second Industrial Zone, Sixth of October City, Giza, EGY
Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents is a pharmaceutical company. The company is engaged in the manufacturing, marketing, selling, and storage of pharmaceutical reagents for both human and veterinary use. It is also involved in manufacturing, marketing, selling and storing diagnostic and pharmaceutical reagents for human, veterinary, and diagnostic use.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Headlines

No Headlines